Zeke Capital Advisors’s Quest Diagnostics DGX Stock Holding History
Bought
Maintained
Sold
Other funds holding DGX
FMI
DSA
Zeke Capital Advisors's DGX Position: Q3 2021 in Review
Zeke Capital Advisors sold out of Quest Diagnostics (DGX) in Q3 2021, closing a stake of 2,584 shares — an estimated $341K sold.
Zeke Capital Advisors first reported a position in DGX in Q4 2017 and held it in 14 quarters. The position peaked at $2.15M in Q3 2018. 837 funds tracked by Wall St. Rank hold DGX as of Q3 2021.
- Zeke Capital Advisors reported no remaining Quest Diagnostics position as of Q3 2021 after selling out during the quarter.
- Zeke Capital Advisors sold 2,584 Quest Diagnostics shares in Q3 2021, an estimated $341K.
- Zeke Capital Advisors first reported a position in Quest Diagnostics in Q4 2017 and held it in 14 quarters.
- Zeke Capital Advisors's Quest Diagnostics position peaked at $2.15M in Q3 2018.
- 837 funds tracked by Wall St. Rank held Quest Diagnostics as of Q3 2021.
Based on Zeke Capital Advisors's 13F filing for Q3 2021, filed 15 Nov 2021.